Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 5,950.00
-50.00 (-0.83%)
At close: Oct 2, 2026
Wonbiogen Market Cap
Wonbiogen has a market cap or net worth of 40.5 billion as of October 2, 2026. Its market cap has increased by 6.12% in one year.
Market Cap
40.50B
Enterprise Value
33.79B
Revenue
37.80B
Ranking
n/a
PE Ratio
4.93
Stock Price
5,950.00
ChartMarket Cap Chart
Since January 26, 2021, Wonbiogen's market cap has decreased from 47.59B to 40.50B, a decrease of -14.91%. That is a compound annual growth rate of -2.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 40.50B | -14.54% |
| Dec 30, 2025 | 47.38B | 16.35% |
| Dec 30, 2024 | 40.72B | -32.55% |
| Dec 28, 2023 | 60.37B | 3.39% |
| Dec 29, 2022 | 58.40B | -21.09% |
| Dec 30, 2021 | 74.00B | 55.49% |
| Jan 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DuChemBIO | 206.88B |
| JW Shinyak | 165.66B |
| CG MedTech | 122.88B |
| Sewoon Medical | 97.01B |
| SCL Science | 89.12B |
| OSTEONIC | 83.55B |
| KM Corporation | 41.93B |
| MEDYSSEY Co.,Ltd | 39.69B |